Cancer Research Institute Launches IGNITE Award to Bridge Critical Funding Gap for Next-Generation Immunotherapy Scientists
admin In October 2025, the Cancer Research Institute (CRI) made a landmark announcement, unveiling the IGNITE...
admin
Sanofi Seeks to Reinvigorate Regeneron Alliance Amid Strategic Reshuffle, While BMS Faces Pipeline Delays and Apnimed’s IPO Signals Biotech Resilience
A dynamic week in the biopharmaceutical sector saw Sanofi’s new leadership publicly commit to mending...
Great Cycle Challenge Announces 2026 Ambassadors and Surpasses 87 Million Dollars in Total Fundraising for Pediatric Cancer Research
The Great Cycle Challenge, a national cycling initiative dedicated to ending childhood cancer, has officially...
Mark Zafra Joins CureSearch for Children’s Cancer Board of Directors to Bolster Strategic Leadership and Mission-Driven Impact
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to accelerating the development of...
Cancer Research Institute Announces 2026 Scientific Achievement Awards for Groundbreaking Immunotherapy Research by Eric Vivier and Joseph Sun
The Cancer Research Institute (CRI) has proudly unveiled the recipients of its prestigious 2026 Scientific...
Ziltivekimab’s Phase 3 Failure Shatters Hopes for Inflammation-Targeting Cardiovascular Drugs, Triggering Widespread Biotech Market Decline.
The biopharmaceutical sector was rocked on July 31, 2026, as Novo Nordisk announced the disappointing...
Gold Ribbon Hero: Macon
The speed with which a family’s trajectory can shift from normalcy to intensive oncology care...
CureSearch Awards 1 Million Dollars to Dr Yael Mossé for High Risk Neuroblastoma Research at Childrens Hospital of Philadelphia
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to accelerating the development of...
Cancer Research Institute Announces 2026 CLIP and Technology Impact Awards, Fueling Next-Generation Immunotherapies
The Cancer Research Institute (CRI), a global leader in advancing immunotherapy, has proudly announced the...
Johnson & Johnson Secures Option to Acquire Sail Biomedicines, Marking Major Bet on In Vivo CAR-T for Autoimmune Diseases
Pharmaceutical giant Johnson & Johnson has taken a significant step into the burgeoning field of...
